Metropolitan Life Insurance Company (MetLife)’s Maravai LifeSciences MRVI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,300	Closed	-$306K	–	2518
2021 Q4	$306K	Buy	7,300 +490	+7%	+$19.8K	﹤0.01%	1732
2021 Q3	$334K	Buy	6,810 +1,585	+30%	+$77.3K	﹤0.01%	1694
2021 Q2	$218K	Buy	5,225 +1,331	+34%	+$51.6K	﹤0.01%	2087
2021 Q1	$139K	Buy	+3,894	New	+$129K	﹤0.01%	2257

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MRVI Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Maravai LifeSciences (MRVI) in Q1 2022, closing a stake of 7,300 shares — an estimated $306K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MRVI in Q1 2021 and held it in 4 quarters. The position peaked at $334K in Q3 2021. 235 funds tracked by Wall St. Rank hold MRVI as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Maravai LifeSciences position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 7,300 Maravai LifeSciences shares in Q1 2022, an estimated $306K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Maravai LifeSciences in Q1 2021 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Maravai LifeSciences position peaked at $334K in Q3 2021.
235 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.